Hypoalbuminemia at diagnosis as a marker for severe respiratory course in infants with cystic fibrosis identified by newborn screening

J Pediatr. 1985 Dec;107(6):933-5. doi: 10.1016/s0022-3476(85)80194-3.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cystic Fibrosis / blood*
  • Cystic Fibrosis / drug therapy
  • Cystic Fibrosis / epidemiology
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Lipase / therapeutic use
  • Male
  • Mass Screening
  • Pancreatic Extracts / therapeutic use
  • Pancreatin / therapeutic use
  • Pancrelipase
  • Respiratory Tract Diseases / prevention & control*
  • Risk
  • Serum Albumin / deficiency*
  • Tablets, Enteric-Coated

Substances

  • Pancreatic Extracts
  • Serum Albumin
  • Tablets, Enteric-Coated
  • Pancrelipase
  • Pancreatin
  • Lipase